Development of a commercial cigarette "market map" comparison methodology for evaluating new or non-conventional cigarettes

Regulatory Toxicology and Pharmacology

Volumn 46, Issue 3, 2006, Pages 225-242

  Counts, M E ^a   Hsu, F S ^a   Tewes, F J ^b  

^a Philip Morris USA Research Center   (United States)

^b Philip Morris Research Laboratories GmbH   (Germany)

Author keywords

1R4F reference cigarette; 2R4F reference cigarette; Commercial cigarettes; Market maps; Smoke chemistry; Smoke in vitro toxicity

Indexed keywords

AMMONIA; CIGARETTE SMOKE; NICOTINE; NITRATE; NITROSAMINE; TAR;

ACCURACY; ANIMAL CELL; ARTICLE; BIOASSAY; CHEMICAL COMPOSITION; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DEVICE; IN VITRO STUDY; MARKET; MARKET MAP; METHODOLOGY; MOUSE; MUTAGENICITY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TOBACCO; TOBACCO INDUSTRY;

ANIMALS; CELL LINE; EMBRYO; LEAD; MARKETING; MICE; MUTAGENICITY TESTS; NITROSAMINES; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS; REFERENCE VALUES; REGRESSION ANALYSIS; SMOKE; TARS; TOBACCO; TOXICITY TESTS; UNITED STATES;

NICOTIANA TABACUM;

EID: 33750623725     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2006.07.002     Document Type: Article

References (56)

1. Ames B.N., McCann J., and Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/Mammalian-Microsome Mutagenicity Test. Mutat. Res. 31 (1975) 347-363
2. Baker R.R. Smoke chemistry. In: Davis D.L., and Nielsen M.T. (Eds). Tobacco Production, Chemistry, and Technology (1999), Blackwell Science Inc., Malden, MA 398-439
3. Baker R.R., Massey E.D., and Smith G. An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 42S (2004) S53-S83
4. Borenfreund E., and Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 24 (1985) 119-124
5. Borgerding, M.F., Bodnar, J.A., Wingate, D.E., Taylor, C.R., Reid, J.R., Sudholz, M.A., Podraza, K.F., Hsu, F.S., Whidby, J.F., 2000. The 1999 Massachusetts Benchmark Study, Final Report. Available from the Massachusetts Department of Public Health under the Massachusetts (US) public records law.
6. Brown, Williamson. 2002. Before the Food and Drug Administration: Comments of Brown and Williamson Tobacco Corporation on the petitions for regulation of Brown and Williamson's "Advance" cigarettes submitted by Nat'l Center for Tobacco-Free Kids, et al., and the Society for Research on Nicotine and Tobacco.
7. Browne C.L. The Design of Cigarettes (1990), Hoechst Celanese Corporation, Charlotte, NC
8. Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 1: Cigarette design, testing approach, and review of results. Food Chem. Toxicol. 40 (2002) 77-91
9. Chen P.X., and Moldoveanu S.C. Mainstream smoke chemical analyses for 2R4F Kentucky reference cigarette. Beitr. Tabakforsch. Int. 20 (2003) 448-458
10. Chepiga T.A., Morton M.J., Murphy P.A., Avalos J.T., Bombick B.R., Doolittle D.J., Borgerding M.F., and Swauger J.E. A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F). Food Chem. Toxicol. 38 (2000) 949-962
11. Clive D., Flamm W.G., Mechesko M.R., and Bernheim N.J. A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat. Res. 16 (1972) 77-87
12. Clive D., Johnson K.O., Spector J.F.S., Batson A.G., and Brown M.M.M. Validation and characterization of the L5178Y/Tk+/- mouse lymphoma mutagen assay system. Mutat. Res. 59 (1979) 61-108
13. Counts M.E., Hsu F.S., Laffoon S.W., Dwyer R.W., and Cox R.H. Mainstream smoke constituent yields and predicting relations from a worldwide market sample of cigarette brands: ISO smoking conditions. Reg. Toxicol. Pharmacol. 39 (2004) 111-134
14. d'Andres S., Boudoux R., Renaud J.-M., and Zuber J. TSNA levels in the mainstream smoke of simplified blend prototypes. Beitr. Tabakforsch. Int. 20 (2003) 331-340
15. Davies H.M., and Vaught A. The Reference Cigarette (2003), Kentucky Tobacco Research and Development Center, University of Kentucky, Lexington, KY
16. Diana J.N., and Vaught A. The Reference Cigarette (1990), Tobacco and Health Research Institute. The University of Kentucky Printing Services, Lexington, KY
17. ECLIPSE Expert Panel, 2000. A safer cigarette? A comparative study. A consensus report. Inhal. Toxicol. 12 (Suppl. 5), 1-48.
18. Federal Register, August 1, 1967. Cigarettes: Testing for Tar and Nicotine Content, vol. 32, No. 147, 11178.
19. Fischer S., Spiegelhalder B., Eisenbarth J., and Preussmann R. Investigations on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. Carcinogenesis 11 (1990) 723-730
20. Gori G.B. Virtually safe cigarettes: reviving an opportunity once tragically rejected (2000), IOS Press Inc., Burke, VA (chapter 9)
21. Green C.R., and Rodgman A. The Tobacco Chemists' Research Conference: A half century forum for advances in analytical methodology of tobacco and its products. Recent Adv. Tobacco Sci. 22 (1996) 131-306
22. Gregg E., Hill C., Hollywood M., Kearney M., McAdam K., McLaughlin D., Purkis S., and Williams M. The UK smoke constituents testing study. Summary results and comparison with other studies. Beitr. Tabakforsch. Int. 21 (2004) 117-138
23. Hoffmann D., and Hoffmann I. The changing cigarette, 1950-1995. J. Toxicol. Environ. Health 50 (1997) 307-364
24. IARC, 1986. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 38. Tobacco Smoking. International Agency for Research on Cancer, Lyon pp. 83-126.
25. INVITTOX, 1990. The FRAME modified neutral red uptake cytotoxicity test. The ERGATT/FRAME data bank of in vitro techniques in toxicology, Protocol No. 3a, INVITTOX, Nottingham.
26. Institute of Medicine, 2001. In: Stratton, K., Shetty, P., Wallace, R., Bondurant, S. (Eds.), Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. National Institutes of Health, National Academy Press, Washington, DC (Chapter 7).
27. ISO Standard 10315, second ed. and Corrigendum I, 2000. International Organization for Standardization. Cigarettes-Determination of nicotine in smoke condensates-Gas chromatographic method.
28. ISO Standard 10362-1, second ed., 1999. International Organization for Standardization. Cigarettes-Determination of water in smoke condensates-Part 1: Gas chromatographic method.
29. ISO Standard 10362-2, 1994. International Organization for Standardization. Cigarettes-Determination of water in smoke condensates-Part 2: Karl Fischer method.
30. ISO Standard 3308, fourth ed., 2000. International Organization for Standardization. Routine analytical cigarette-smoking machine-Definitions and standard conditions.
31. ISO Standard 8243. third ed., 2003. International Organization for Standardization. Cigarettes-Sampling.
32. ISO Standard 8454, second ed., 1995. International Organization for Standardization. Cigarettes-Determination of carbon monoxide in the vapour phase of cigarette smoke-NDIR method.
33. Maron D.M., and Ames B.N. Revised methods for the Salmonella Mutagenicity Test. Mutat. Res. 113 (1983) 173-215
34. Massachusetts, 1997. Massachusetts General Laws, Ch. 94, Sect. 307B, 105 Code of Massachusetts Regulations 660.000 et seq.
35. Maxwell, J.C. Jr. February 2002. Year 2001 and fourth quarter 2001 sales estimates for the cigarette industry. 4703 Rolfe Road, Richmond, VA.
36. Norman A. Cigarette design and materials. In: Davis D.L., and Nielsen M.T. (Eds). Tobacco Production, Chemistry, and Technology (1999), Blackwell Science, Inc., Malden, MA 353-387
37. OECD, 1997a. Guideline 471 (updated). Bacterial reverse mutation test. In: OECD Guidelines for Testing of Chemicals. Organization for Economic Co-operation and Development, OECD Publishing, Paris.
38. OECD, 1997b. Guideline 476 (updated). In vitro mammalian cell gene mutation test. In: OECD Guidelines for Testing of Chemicals. Organization for Economic Co-operation and Development, OECD Publishing, Paris.
39. Patskan G., and Reininghaus W. Toxicological evaluation of an electrically heated cigarette. Part 1: Overview of technical concepts and summary of findings. J. Appl. Toxicol. 23 (2003) 323-328
40. Pillsbury H.C., Bright C.C., O'Connor K.J., and Irish F.W. Tar and nicotine in cigarette smoke. J. Assoc. Off. Anal. Chem. 52 (1969) 458-462
41. Purkis S.W., Hill C.A., and Bailey I.A. Current measurement reliability of selected smoke analytes. Beitr. Tabakforsch. Int. 20 (2003) 314-324
42. Roemer E., Tewes F.J., Meisgen T.J., Veltel D.J., and Carmines E.L. Evaluation of potential effects of ingredients added to cigarettes. Part 3: In vitro genotoxicity and cytotoxicity. Food Chem. Toxicol. 40 (2002) 105-111
43. Roemer E., Stabbert R., Rustemeier K., Veltel D.J., Meisgen T.J., Reininghaus W., Carchman R.A., Gaworski C.L., and Podraza K.F. Chemical composition, cytotoxicity and mutagenicity of smoke from commercial and reference cigarettes smoke under two sets of machine smoking conditions. Toxicology 195 (2004) 31-52
44. Rustemeier K., Stabbert R., Haussmann H.-J., Roemer E., and Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke. Food Chem. Toxicol. 40 (2002) 93-104
45. Schramke H., Tewes F.J., and Roemer E. Using the mouse lymphoma TK assay to compare the mutagenicity of mainstream smoke condensate from research cigarettes. The Toxicologist 66 1-S (2002) 71
46. Stabbert R., Voncken P., Rustemeier K., Haussmann H.-J., Roemer E., Schaffernicht H., and Patskan G. Toxicological evaluation of an electrically heated cigarette. Part 2. Chemical composition of mainstream smoke. J. Appl. Toxicol. 23 (2003) 329-339
47. Steele R.H., Payne V.M., Fulp C.W., Rees D.C., Lee C.K., and Doolittle D.J. A comparison of the mutagenicity of mainstream cigarette smoke condensates from a representative sample of the U.S. cigarette market with a Kentucky reference cigarette (KY1R4F). Mutat. Res. 342 (1995) 179-190
48. Swauger J.E., Steichen T.J., Murphy P.A., and Kinsler S. An analysis of the mainstream smoke chemistry of samples of the U.S. cigarette market acquired between 1995 and 2000. Regul. Toxicol. Pharmacol. 35 (2002) 142-156
49. Terpstra P.M., Teredesai A., Vanscheeuwijck P.M., Verbeeck J., Schepers G., Radtke F., Kuhl P., Gomm W., Anskeit E., and Patskan G. Toxicological evaluation of an electrically heated cigarette. Part 4: Subchronic inhalation toxicology. J. Appl. Toxicol. 23 (2003) 349-362
50. Tewes F.J., Meisgen T.J., Veltel D.J., Roemer E., and Patskan G. Toxicological evaluation of an electrically heated cigarette. Part 3. Genotoxicity and cytotoxicity of mainstream smoke. J. Appl. Toxicol. 23 (2003) 341-348
51. Texas. 1998. Administrative Code, Title 25, Part. 1. Chapter 101.1 et seq and Texas Health and Safety Code, Subchapter N, Section 161.251 et seq.
52. TITL. April 24, 2003. Tobacco Industry Testing Laboratory Market Sample 45 Final Report: "Tar," "Nicotine," and Carbon Monoxide Values. Tobacco Industry Testing Laboratory, Inc., 9900 Campus Drive, Suite 300, Rockville, MD, USA.
53. Torrence K.M., McDaniel R.L., Self D.A., and Chang M.J. Slurry sampling for the determination of arsenic, cadmium, chromium and lead in mainstream cigarette smoke condensate by graphite furnace atomic absorption spectroscopy and inductively coupled plasma mass spectrometry. Anal. Bioanal. Chem. 372 (2002) 723-731
54. US Consumer Product Safety Commission (US CPSC). 1993. Toxicity testing plan for low ignition-potential cigarettes, vol. 5, Part 1. US CPSC, Washington, DC.
55. Vanscheeuwijck P.M., Teredesai A., Terpstra P.M., Verbeeck J., Kuhl P., Gerstenberg B., Gebel S., and Carmines E.L. Evaluation of potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity. Food Chem. Toxicol. 40 (2002) 113-131
56. Zar J.H. Biostatistical Analysis. second ed. (1984), Prentice Hall Inc, Englewood Cliffs, NJ (chapter 18)